Inhaled nitric oxide: More than a selective pulmonary vasodilator

Critical Care Medicine

Volumn 28, Issue 4, 2000, Pages 1235-1236

  Quezado, Zenaide M N ^a   Eichacker, Peter Q ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Inflammation; Inhaled nitric oxide; Leukocyte; Sepsis; Systemic effects; Vasodilator

Indexed keywords

NITRIC OXIDE; VASODILATOR AGENT;

ADULT RESPIRATORY DISTRESS SYNDROME; DOG; DRUG EFFECT; EDITORIAL; HUMAN; INFLAMMATION; LEUKOCYTE; LUNG BLOOD VESSEL; NONHUMAN; OXYGENATION; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME; SEPSIS; VASODILATATION;

EID: 0034057468     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-200004000-00063     Document Type: Editorial

References (16)

1. 1. Rossaint R, Falke KJ, Lopez F, et al: Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 1993; 328:399-405
2. 2. Rimar S, Gillis CN: Selective pulmonary vasodilation by inhaled nitric oxide is due to hemoglobin inactivation. Circulation 1993; 88:2884-2887
3. 3. Michael JR, Barton RG, Saffle JR, et al: Inhaled nitric oxide versus conventional therapy: effect on oxygenation in ARDS. Am J Respir Crit Care Med 1998; 157:1372-1380
4. 4. Dellinger RP, Zimmerman JL, Taylor RW, et al: Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: results of a randomized phase II trial. Inhaled Nitric Oxide in ARDS Study Group. Crit Care Med 1998; 26:15-23
5. 5. Lundin S, Mang H, Smithies M, et al: Inhalation of nitric oxide in acute lung injury: Results of a European multicentre study. Intensive Care Med 1999; 25:911-919
6. 6. Sato Y, Walley KR, Klut ME, et al: Nitric oxide reduces the sequestration of polymorphonuclear leukocytes in lung by changing deformability and CD18 expression. Am J Respir Crit Care Med 1999; 159:1469-1476
7. 7. Guidot DM, Hybertson BM, Kitlowski RP, et al: Inhaled NO prevents IL-1-induced neutrophil accumulation and associated acute edema in isolated rat lungs. Am J Physiol 1996; 271:L225-L229
8. 8. Gessler P, Nebe T, Birle A, Mueller W, Kachel W: A new side effect of inhaled nitric oxide in neonates and infants with pulmonary hypertension: functional impairment of the neutrophil respiratory burst. Intensive Care Med 1996; 22:252-258
9. 9. Bloomfield GL, Holloway S, Ridings PC, et al: Pretreatment with inhaled nitric oxide inhibits neutrophil migration and oxidative activity resulting in attenuated sepsis-induced acute lung injury. Crit Care Med 1997; 25: 584-593
10. 10. Kermarrec N, Zunic P, Beloucif S, et al: Impact of inhaled nitric oxide on platelet aggregation and fibrinolysis in rats with endotoxic lung injury. Role of cyclic guanosine 5′-monophosphate. Am J Respir Crit Care Med 1998; 158:833-839
11. 11. Wessel DL, Adatia I, Giglia TM, et al: Use of inhaled nitric oxide and acetylcholine in the evaluation of pulmonary hypertension and endothelial function after cardiopulmonary bypass. Circulation 1993; 88:2128-2138
12. 12. Quezado ZM, Natanson C, Karzai W, et al: Cardiopulmonary effects of inhaled nitric oxide in normal dogs and during E. coli pneumonia and sepsis. J Appl Physiol 1998; 84: 107-115
13. 13. Keaney JFJ, Simon DI, Stamler JS, et al: NO forms an adduct with serum albumin that has endothelium-derived relaxing factor-like properties. J Clin Invest 1993; 91:1582-1589
14. 14. Gow AJ, Luchsinger BP, Pawloski JR, et al: The oxyhemoglobin reaction of nitric oxide. Proc Natl Acad Sci USA 1999; 96:9027-9032
15. 15. Nevière R, Mordon S, Maréchal X, et al: Inhaled nitric oxide modulates leukocyte kinetics in the mesenteric venules of endotoxemic rats. Crit Care Med 2000; 28:1072-1076
16. 16. Fox-Robichaud A, Payne D, Hasan SU, et al: Inhaled NO as a viable antiadhesive therapy for ischemia/reperfusion injury of distal microvascular beds. J Clin invest 1998; 101: 2497-2505